|
CAS号: | 1062243-51-9 |
英文名称: | RO3280 |
英文同义词: | RO3280;Ro5203280;4-[(9-Cyclopentyl-7,7-difluoro-6,7,8,9-tetrahydro-5-methyl-6-oxo-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-N-(1-methyl-4-piperidinyl)benzamide;Benzamide, 4-[(9-cyclopentyl-7,7-difluoro-6,7,8,9-tetrahydro-5-methyl-6-oxo-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-;4-[(9-Cyclopentyl-7,7-difluoro-6,7,8,9-tetrahydro-5-methyl-6-oxo-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-N-(1-methyl-4-piperidinyl)benzam Ro 3280 |
中文名称: | RO3280 |
中文同义词: | |
CBNumber: | CB92628362 |
分子式: | C27H35F2N7O3 |
分子量: | 543.6087064 |
MOL File: | 1062243-51-9.mol |
|
|
|
|
RO3280 性质、用途与生产工艺 |
生物活性
Ro3280是一种有效的,高选择性Polo-like kinase 1(PLK1)抑制剂,IC50为3 nM。
|
|
体外研究
RO3280强烈抑制肺癌细胞株H82,大肠癌细胞HT-29,乳腺癌细胞MDA-MB-468,前列腺癌细胞PC3和皮肤癌细胞A375增殖,IC50为分别5 nM,10 nM,19 nM,12 nM和70 nM。
|
|
体内研究
在植入HT-29人大肠肿瘤的裸鼠中,RO3280表现强大的抗肿瘤活性,从40毫克/公斤每周一次剂量时的72%肿瘤生长抑制到更频繁地用药到肿瘤完全消退。
|
|
|
|
|
|
|
1062243-51-9, RO3280 相关搜索: |
2-[[5-[3-(二甲基氨基)丙基]-2-甲基-3-吡啶基]氨基]-5,7-二氢-9-(三氟甲基)- 6H-嘧啶并[5,4-D][1]苯并氮杂卓-6-硫酮
尼达尼布
GSK461364
Trametinib (GSK1120212)
NMS-P937 (NMS1286937)
Volasertib (BI 6727)
|
细胞周期
C27H35F2N7O3
1062243-51-9
4-[(9-Cyclopentyl-7,7-difluoro-6,7,8,9-tetrahydro-5-methyl-6-oxo-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-N-(1-methyl-4-piperidinyl)benzam Ro 3280
Benzamide, 4-[(9-cyclopentyl-7,7-difluoro-6,7,8,9-tetrahydro-5-methyl-6-oxo-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-
Ro5203280
4-[(9-Cyclopentyl-7,7-difluoro-6,7,8,9-tetrahydro-5-methyl-6-oxo-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-N-(1-methyl-4-piperidinyl)benzamide
RO3280
|
Copyright 2016 © ChemicalBook. All rights reserved |